Isolated human right atrial preparations: force of contraction and its pharmacological modulation
“Inotropic effects of retatrutide in isolated human atrial preparations.”
Neumann J, Ahlrep U, Hofmann B, Gergs UNaunyn-Schmiedeberg's Archives of Pharmacology2026PMID 40613938 (opens PubMed in a new tab)DOI 10.1007/s00210-025-04421-3 (opens the publisher record in a new tab)
Filed under GLP-3
- Model
- Right atrial preparations obtained during cardiac surgery from 29 patients (24 men and 5 women, aged 52–84); isometric force measurement under electrical stimulation in an organ bath
- Sample size
- 29
- Exposure
- Retatrutide added to the isolated tissue at increasing concentrations, with and without a phosphodiesterase-3 inhibitor (cilostamide)
- Comparator
- Force of contraction before exposure; selective antagonists of the peptide's three receptors; propranolol, carbachol, stimulation of adenosine A1 receptors and ryanodine
Study by an academic group without affiliation to the developer. In isolated human right atrial preparations, retatrutide increased force of contraction in a concentration- and time-dependent manner; with the phosphodiesterase-3 inhibitor cilostamide present, the effect was larger and relaxation time shortened. The effect was reduced by selective antagonists of its three receptors and by carbachol, stimulation of adenosine A1 receptors and ryanodine, but not by propranolol; the authors interpret it as a cAMP-mediated action through those receptors rather than through β-adrenergic receptors. The sinus node and ventricular tissue were not examined.